A woman from WA has become the second Australian to suffer a rare blood clotting condition after receiving the AstraZeneca vaccine.
The woman aged in her 40s is in a stable condition in hospital after being diagnosed with a case of “thrombosis with thrombocytopenia”.
The Therapeutic Goods Administration (TGA) issued a statement on Tuesday and said the case is "likely to be linked to the vaccination".
"The panel concluded that the case is similar to cases seen in Europe and the United Kingdom of a rare clotting disorder, referred to as 'thrombosis with thrombocytopenia syndrome' (TTS)."
There have been about 700,000 doses of AstraZeneca vaccines administered in Australia to date.
The second case now means one in 350,000 AstraZeneca vaccinations administered in the country have potential ties to blood clots.
"The TGA is carefully reviewing all Australian reports of blood clots following the AstraZeneca vaccine," the statement read.
People who have received the vaccine should seek immediate medical attention if they develop symptoms such as a severe or persistent headache, blurred vision, shortness of breath, chest pain, leg swelling or unusual skin bruising and/or pinpoint round spots beyond the site of injection.
Mission Australia celebrates 25 years of supporting young people through Mandurah Reconnect program
'Mad Eagles fan' wins $6 million Lotto prize
Mandurah woman loses everything in house fire
Gift card scams surge past $1 million prompting urgent warning from Consumer Protection
Secret Harbour by-election attracts record 16 candidates
Major party candidates locked-in for looming Secret Harbour by-election
Comet Bay Primary to offer full-time kindy from 2027
North Dandalup crash claims life of driver
Date set for Mandurah's Town Ward Extraordinary Election